Its involvement in JAK2 signaling was shown in mouse JAK2-deficient HSCs [23,44], and its overexpression in JAK-mutated HSCs appears to contribute to the MPN phenotype in vivo [23,45]. This evidence concerns the gene JAK2 and myeloproliferative disorder.